Prelude Therapeutics, Inc. (PRLD)

3.88 +0.05 (+1.31%) USD  |  NASDAQ  |  Oct 08, 16:00
3.88 0.00 (0.00%) After-Hours: 20:00
More

Prelude Therapeutics Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for PRLD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
September 17, 2026 --
August 12, 2026 --
August 11, 2026 --
July 29, 2026 --
July 15, 2026 --
May 27, 2026 --
May 13, 2026 --
May 12, 2026 --
May 04, 2026 --
April 27, 2026 --
April 21, 2026 --
March 12, 2026 --
March 11, 2026 --
February 04, 2026 --
December 08, 2025 --
November 13, 2025 --
Date Value
November 12, 2025 --
November 05, 2025 --
November 04, 2025 --
September 23, 2025 --
August 18, 2025 --
August 14, 2025 --
May 07, 2025 --
May 05, 2025 --
April 29, 2025 --
April 08, 2025 --
March 12, 2025 --
October 28, 2024 --
October 25, 2024 --
August 12, 2024 --
August 05, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Q32 Bio, Inc. Upgrade
Intellia Therapeutics, Inc. Upgrade
Twist Bioscience Corp. Upgrade
Beam Therapeutics, Inc. Upgrade
Revolution Medicines, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade